Original language | English (US) |
---|---|
Pages (from-to) | 343-345 |
Number of pages | 3 |
Journal | Cancer Cell |
Volume | 40 |
Issue number | 4 |
DOIs | |
State | Published - Apr 11 2022 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave. / Lee, Matthew; Quinn, Ryann; Pradhan, Kith et al.
In: Cancer Cell, Vol. 40, No. 4, 11.04.2022, p. 343-345.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Impact of COVID-19 on case fatality rate of patients with cancer during the Omicron wave
AU - Lee, Matthew
AU - Quinn, Ryann
AU - Pradhan, Kith
AU - Fedorov, Kateryna
AU - Levitz, David
AU - Fromowitz, Ariel
AU - Thakkar, Astha
AU - Shapiro, Lauren C.
AU - Kabarriti, Rafi
AU - Ruiz, Rafael E.
AU - Andrews, Erin M.
AU - Thota, Raja
AU - Chu, Edward
AU - Kalnicki, Shalom
AU - Goldstein, Yitz
AU - Loeb, David
AU - Racine, Andrew
AU - Halmos, Balazs
AU - Mehta, Vikas
AU - Verma, Amit
N1 - Funding Information: The authors acknowledge LLS Award IRV-BC0004-22 , Cancer Center grant P30 CA013330 , NCI COVID Supplement 21-1175 , and NCORP grant NIH5UG1 CA189859-08 for providing funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding Information: The authors acknowledge LLS Award IRV-BC0004-22, Cancer Center grant P30 CA013330, NCI COVID Supplement 21-1175, and NCORP grant NIH5UG1 CA189859-08 for providing funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.V. has received research funding from Prelude, BMS, GSK, Incyte, Medpacto, Curis, and Eli Lilly; is a scientific advisor for Stelexis, Bakx, and Curis; receives honoraria from Stelexis and Janssen; and holds equity in Stelexis, Bakx, and Throws Exception. The other authors declare no competing interests.
PY - 2022/4/11
Y1 - 2022/4/11
UR - http://www.scopus.com/inward/record.url?scp=85127575873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127575873&partnerID=8YFLogxK
U2 - 10.1016/j.ccell.2022.02.012
DO - 10.1016/j.ccell.2022.02.012
M3 - Letter
C2 - 35219358
AN - SCOPUS:85127575873
SN - 1535-6108
VL - 40
SP - 343
EP - 345
JO - Cancer Cell
JF - Cancer Cell
IS - 4
ER -